Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2022

View Archived Issues

CAMLG gene mutation c.633+4A>G causes a novel neurological phenotype

Medulloblastoma murine model dissects its poorly known biology

Variant in ABO blood group gene associated with long COVID

Hangzhou Polymed Biopharmaceuticals identifies new G12C mutant KRAS inhibitors

New phosphodiesterase PDE4B1 inhibitors discovered at Reistone Biopharma

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group patent vasopressin receptor antagonists

Peking University describes radiation-activated tetravalent platinum complex

New cyclin-dependent kinase inhibitors divulged by Allorion Therapeutics

Ovarian fibrosis-mediated ovulation failure is reversible: study

Study identifies novel genes causing male infertility

New mouse model displays stable hyperglycemia without age-related morbidity

IND clearance for anti-CD20 armed allogeneic gamma delta T-cell therapy ACE-1831 for NHL

miR-662 revealed as a metastatis-to-bone marker in breast cancer

Use of [177Lu]Lu-CCZ01158 shows promise for the treatment of human melanoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...